Community Series in Novel Biomarkers for Predicting Response to Cancer Immunotherapy: Volume III

2,597
Total downloads
11k
Total views and downloads

Participate in this topic

Articles

SYSTEMATIC REVIEW

Accepted on 28 Apr 2025

Prognostic value of the Systemic Immune-Inflammation Index in Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis

Guorong Chen
Bahu Bao
Yucai Ye
Aoyan Hu
Jingzi Sun
Weiying Liu

doi 10.3389/fonc.2025.1532343

ORIGINAL RESEARCH

Accepted on 28 Apr 2025

GPR65 is a novel immune biomarker and regulates the immune microenvironment in lung adenocarcinoma

Hanxu Zhou
Zhi Chen
Shuang Gao
Chaoqun Lian
Junjie Hu
Jin Lu
Lei Zhang

doi 10.3389/fimmu.2025.1572757

ORIGINAL RESEARCH

Accepted on 21 Apr 2025

Toll-like Receptor 3 Activation Enhances Antitumor Immune Response in Lung Adenocarcinoma through NF-κB Signaling Pathway

Ang Li
Xiyao Liu
Hongjiao Wu
Xiaoguang Liu
Zhi Zhang
Xuemei Zhang

doi 10.3389/fimmu.2025.1585747

REVIEW

Accepted on 18 Apr 2025

Recent Advances in Biomarkers for Predicting the Efficacy of Immunotherapy in Non-Small Cell Lung Cancer

Jiacheng Zhang
Zehao Song
Yuanjie Zhang
Chentong Zhang
Qi Xue
Guochao Zhang
Fengwei Tan

doi 10.3389/fimmu.2025.1554871

156 views

ORIGINAL RESEARCH

Published on 17 Apr 2025

BTG2-deficient mast cells remodel the tumor and tumor-draining lymph node microenvironment leading to chemotherapy resistance in breast cancer

Xiaoqian Zhang
Jiayi Wang
Ziyu Liu
Jiahuai Wen
Mengling Kang
Chen Fang
Liping Ren

doi 10.3389/fimmu.2025.1562700

402 views

ORIGINAL RESEARCH

Published on 04 Apr 2025

Development and validation of a disulfidptosis-related genes signature for predicting outcomes and immunotherapy in acute myeloid leukemia

Han Gong
Ying Zhang
Xusheng Wu
Yiming Pan
Mingwei Wang
Xiaofeng He
Jing Liu
Zhong Liu
Ling Li

doi 10.3389/fimmu.2025.1513040

791 views

REVIEW

Published on 24 Feb 2025

IFIT3: a crucial mediator in innate immunity and tumor progression with therapeutic implications

Rihan Wu
Hao Yang
Chunlei Liu

doi 10.3389/fimmu.2025.1515718

770 views

ORIGINAL RESEARCH

Published on 24 Feb 2025

Identification and functional characterization of T-cell exhaustion-associated lncRNA AL031775.1 in osteosarcoma: a novel therapeutic target

Yameng Wang
Jinghong Yuan
Keying Guo
Zhuoer Zhang
Junchao Zhu
Shahrzad Arya
Guowen Huang
Shengqin Li
Qi Chen
1 more
Jingyu Jia

doi 10.3389/fimmu.2025.1517971

878 views

ORIGINAL RESEARCH

Published on 17 Feb 2025

Multi-omics analysis identifies UBA family as potential pan-cancer biomarkers for tumor prognosis and immune microenvironment infiltration

Haibin Wang
XinLi Liu
Hesen Huang
Meng Tang
Jiwei Li
Tingting Huang
Shengjie Wang

doi 10.3389/fimmu.2025.1510503

798 views

ORIGINAL RESEARCH

Published on 27 Jan 2025

Unveiling immunogenic characteristics and neoantigens in endometrial cancer with POLE hotspot mutations for improved immunotherapy

Jian Huang
Shuangna Song
Yihua Yin
Yinyan He
Huimin Wang
Ye Gu
Laman He
Xintao Wang
Xiaocao Miao
2 more
Yiran Li

doi 10.3389/fimmu.2025.1528532

926 views

METHODS

Published on 20 Jan 2025

TMBocelot: an omnibus statistical control model optimizing the TMB thresholds with systematic measurement errors

Xin Lai
Shaoliang Wang
Xuanping Zhang
Xiaoyan Zhu
Yuqian Liu
Zhili Chang
Xiaonan Wang
Yang Shao
Jiayin Wang
Yixuan Wang

doi 10.3389/fimmu.2024.1514295

563 views

ORIGINAL RESEARCH

Published on 09 Jan 2025

Subtype-specific human endogenous retrovirus K102 envelope protein is a novel serum immunosuppressive biomarker of cancer

Qinyuan Gong
Rongzhen Xu

doi 10.3389/fimmu.2024.1533740

912 views

Share on

Frontiers in Immunology

Cancer Immunity and Immunotherapy

Participating Journals

Frontiers in Oncology
- Cancer Immunity and Immunotherapy
- 3.5 impact factor
- 6.2 citescore

Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.

Impact

11kTopic views
6,961Article views
2,597Article downloads

View impact

Articles

Prognostic value of the Systemic Immune-Inflammation Index in Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis

GPR65 is a novel immune biomarker and regulates the immune microenvironment in lung adenocarcinoma

Toll-like Receptor 3 Activation Enhances Antitumor Immune Response in Lung Adenocarcinoma through NF-κB Signaling Pathway

Recent Advances in Biomarkers for Predicting the Efficacy of Immunotherapy in Non-Small Cell Lung Cancer

BTG2-deficient mast cells remodel the tumor and tumor-draining lymph node microenvironment leading to chemotherapy resistance in breast cancer

Development and validation of a disulfidptosis-related genes signature for predicting outcomes and immunotherapy in acute myeloid leukemia

IFIT3: a crucial mediator in innate immunity and tumor progression with therapeutic implications

Identification and functional characterization of T-cell exhaustion-associated lncRNA AL031775.1 in osteosarcoma: a novel therapeutic target

Multi-omics analysis identifies UBA family as potential pan-cancer biomarkers for tumor prognosis and immune microenvironment infiltration

Unveiling immunogenic characteristics and neoantigens in endometrial cancer with POLE hotspot mutations for improved immunotherapy

TMBocelot: an omnibus statistical control model optimizing the TMB thresholds with systematic measurement errors

Subtype-specific human endogenous retrovirus K102 envelope protein is a novel serum immunosuppressive biomarker of cancer

Frontiers in Immunology

Cancer Immunity and Immunotherapy

Participating Journals

Frontiers in Oncology

Cancer Immunity and Immunotherapy